INC280 Combined With Bevacizumab in Patients With Glioblastoma Multiforme

NCT02386826 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

65

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma Multiforme
Gliosarcoma
Colorectal Cancer
Renal Cell Carcinoma

Interventions

DRUG: INC280
BIOLOGICAL: bevacizumab

Sponsor

SCRI Development Innovations, LLC

Collaborators

[object Object]